NasdaqCM - Delayed Quote USD

Scinai Immunotherapeutics Ltd. (SCNI)

2.4800
-0.0700
(-2.75%)
At close: June 9 at 4:00:01 PM EDT
2.3200
-0.16
(-6.45%)
Pre-Market: 8:31:58 AM EDT

Valuation Measures

Annual Monthly
Currency in USD Download
Current12/31/20249/30/20246/30/20243/31/202412/31/2023
Market Cap 2.48M 2.85M 2.94M 1.62M 2.41M 2.59M
Enterprise Value 8.23M 8.68M 20.69M 17.31M 15.85M 16.04M
Trailing P/E -- 1.39 -- -- -- --
Forward P/E -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- --
Price/Sales 3.04 6.31 6.21 -- -- --
Price/Book 0.57 0.65 -- -- -- --
Enterprise Value/Revenue 12.51 19.19 72.86 73.93 -- --
Enterprise Value/EBITDA 1.05 1.11 -- -- -- --
12/31/2023 - 5/11/2015

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2024
Most Recent Quarter (mrq) 12/31/2024

Profitability

Profit Margin 728.88%
Operating Margin (ttm) -1,098.54%

Management Effectiveness

Return on Assets (ttm) -34.92%
Return on Equity (ttm) 177.37%

Income Statement

Revenue (ttm) 658k
Revenue Per Share (ttm) 0.82
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) -580k
EBITDA -6.99M
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) 0.0000
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 1.96M
Total Cash Per Share (mrq) 0
Total Debt (mrq) 2.09M
Total Debt/Equity (mrq) 20.91%
Current Ratio (mrq) 1.32
Book Value Per Share (mrq) 5.10

Cash Flow Statement

Operating Cash Flow (ttm) -6.33M
Levered Free Cash Flow (ttm) -3.82M

Trading Information

Stock Price History

Beta (5Y Monthly) 2.09
52 Week Change 3 -10.14%
S&P 500 52-Week Change 3 11.73%
52 Week High 3 8.9200
52 Week Low 3 1.9000
50-Day Moving Average 3 2.5791
200-Day Moving Average 3 3.2644

Share Statistics

Avg Vol (3 month) 3 350.67k
Avg Vol (10 day) 3 2.13M
Shares Outstanding 5 999.92k
Implied Shares Outstanding 6 937.14k
Float 8 2.44B
% Held by Insiders 1 18.22%
% Held by Institutions 1 26.55%
Shares Short (5/15/2025) 4 430
Short Ratio (5/15/2025) 4 0.03
Short % of Float (5/15/2025) 4 0.04%
Short % of Shares Outstanding (5/15/2025) 4 0.04%
Shares Short (prior month 4/15/2025) 4 772

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 1:10
Last Split Date 3 5/21/2024

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending

Related Tickers